Evidence map›Paper›PMID 32162336›Full record

ArticleCancer2020

Annual report to the nation on the status of cancer, part I: National cancer statistics.

S Jane Henley, Elizabeth M Ward, Susan Scott, Jiemin Ma, Robert N Anderson, Albert U Firth, Cheryll C Thomas, Farhad Islami, Hannah K Weir, Denise Riedel Lewis and 7 more

Abstract read
In one paragraph

Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 407 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
407citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

407 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Cancer Among Asian Americans and Pacific Islanders, 1999-2020.Journal of racial and ethnic health disparities · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

347 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

S Jane HenleyDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0002-2420-306X
Elizabeth M WardNorth American Association of Central Cancer Registries, Springfield, Illinois.
Susan ScottDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0001-5881-8313
Jiemin MaSurveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.ORCID 0000-0002-1101-8156
Robert N AndersonNational Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland.
Albert U FirthInformation Management Services, Inc., Rockville, Maryland.
Cheryll C ThomasDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Farhad IslamiSurveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.ORCID 0000-0002-7357-5994
Hannah K WeirDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-6568-9708
Denise Riedel LewisDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-3385-2958
Recinda L ShermanNorth American Association of Central Cancer Registries, Springfield, Illinois.
Manxia WuDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Vicki B BenardDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lisa C RichardsonDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ahmedin JemalSurveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.ORCID 0000-0002-0000-4111
Kathleen CroninDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Betsy A KohlerNorth American Association of Central Cancer Registries, Springfield, Illinois.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundThe American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States.

methodsData on new cancer diagnoses during 2001 through 2016 were obtained from the Centers for Disease Control and Prevention-funded and National Cancer Institute-funded population-based cancer registry programs and compiled by the North American Association of Central Cancer Registries. Data on cancer deaths during 2001 through 2017 were obtained from the National Center for Health Statistics' National Vital Statistics System. Trends in incidence and death rates for all cancers combined and for the leading cancer types by sex, racial/ethnic group, and age were estimated by joinpoint analysis and characterized by the average annual percent change during the most recent 5 years (2012-2016 for incidence and 2013-2017 for mortality).

resultsOverall, cancer incidence rates decreased 0.6% on average per year during 2012 through 2016, but trends differed by sex, racial/ethnic group, and cancer type. Among males, cancer incidence rates were stable overall and among non-Hispanic white males but decreased in other racial/ethnic groups; rates increased for 5 of the 17 most common cancers, were stable for 7 cancers (including prostate), and decreased for 5 cancers (including lung and bronchus [lung] and colorectal). Among females, cancer incidence rates increased during 2012 to 2016 in all racial/ethnic groups, increasing on average 0.2% per year; rates increased for 8 of the 18 most common cancers (including breast), were stable for 6 cancers (including colorectal), and decreased for 4 cancers (including lung). Overall, cancer death rates decreased 1.5% on average per year during 2013 to 2017, decreasing 1.8% per year among males and 1.4% per year among females. During 2013 to 2017, cancer death rates decreased for all cancers combined among both males and females in each racial/ethnic group, for 11 of the 19 most common cancers among males (including lung and colorectal), and for 14 of the 20 most common cancers among females (including lung, colorectal, and breast). The largest declines in death rates were observed for melanoma of the skin (decreasing 6.1% per year among males and 6.3% among females) and lung (decreasing 4.8% per year among males and 3.7% among females). Among children younger than 15 years, cancer incidence rates increased an average of 0.8% per year during 2012 to 2016, and cancer death rates decreased an average of 1.4% per year during 2013 to 2017. Among adolescents and young adults aged 15 to 39 years, cancer incidence rates increased an average of 0.9% per year during 2012 to 2016, and cancer death rates decreased an average of 1.0% per year during 2013 to 2017.

conclusionsAlthough overall cancer death rates continue to decline, incidence rates are leveling off among males and are increasing slightly among females. These trends reflect population changes in cancer risk factors, screening test use, diagnostic practices, and treatment advances. Many cancers can be prevented or treated effectively if they are found early. Population-based cancer incidence and mortality data can be used to inform efforts to decrease the cancer burden in the United States and regularly monitor progress toward goals.

Indexed as

American Cancer SocietyCenters for Disease Control and Prevention, U.S.Cross-Sectional StudiesFemaleHumansIncidenceMaleMortalityNational Cancer Institute (U.S.)NeoplasmsRegistriesSex CharacteristicsUnited Statesand End Results (SEER) programAnnual Report to the NationcancerepidemiologyEpidemiologyincidencemortalityNational Program of Cancer Registries (NPCR)National Vital Statistics System (NVSS)North American Association of Central Cancer Registries (NAACCR)Surveillancetrends

Identifiers

PMID32162336
PMCPMC7299151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.